Oral Endocrine Therapy Nonadherence, Adverse Effects, Decisional Support, and Decisional Needs in Women With Breast Cancer
Conclusions:
Adverse effects contribute to BCSs decisions to stop OET, yet there has been little investigation of the process through which that occurs. This review serves as a call to action for providers to provide support to BCSs experiencing OET adverse effects and facing decisions related to nonadherence.
Implications for Practice:
Findings suggest BCSs prescribed OET have unmet decisional needs, and more decisional supports are needed for BCSs experiencing OET adverse effects.
Source: Cancer Nursing - Category: Nursing Tags: Articles: Online Only Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Nurses | Nursing | Oral Cancer | Study | Tamoxifen | Women